Aortic Regurgitation

Aortic Regurgitation (AR) is a valvular heart disease characterized by the backflow of blood from the aorta into the left ventricle during diastole due to incomplete closure of the aortic valve. This diastolic volume overload leads to left ventricular dilation and hypertrophy, as the ventricle must pump a larger stroke volume to maintain forward flow. Over time, chronic AR can lead to left ventricular dysfunction, heart failure, and other cardiovascular complications if left untreated.

Aortic regurgitation can be caused by intrinsic disease of the aortic valve leaflets or by dilation of the aortic root, which prevents coaptation of otherwise normal leaflets.
Valvular Causes: Congenital: Bicuspid aortic valve (most common cause in developed countries), quadricuspid valve.
Acquired: Rheumatic Fever: A significant cause globally, especially in developing countries, leading to scarring and retraction of valve leaflets.

• Infective Endocarditis: Infection of the valve causing leaflet destruction or perforation.


• Degenerative Valve Disease: Calcification and fibrosis of valve leaflets, often associated with aging.


• Trauma: Chest trauma leading to valve leaflet avulsion.

• Aortic Aneurysm/Dissection: Expansion or tear in the aorta, affecting valve support.


• Connective Tissue Disorders: Marfan syndrome, Ehlers-Danlos syndrome, Loeys-Dietz syndrome, which weaken aortic tissue.


• Inflammatory/Autoimmune Conditions: Systemic lupus erythematosus (SLE), rheumatoid arthritis, ankylosing spondylitis, giant cell arteritis, syphilis (tertiary).


• Aging: Age-related loss of elastic tissue in the aortic wall.

In aortic regurgitation, blood leaks from the aorta back into the left ventricle during diastole. This causes a significant increase in the left ventricular (LV) end-diastolic volume (preload), leading to LV volume overload. To eject this increased volume, the LV compensates by undergoing eccentric hypertrophy (dilation and wall thickening) and increasing its contractility (Frank-Starling mechanism). This compensatory mechanism initially maintains cardiac output, and patients may remain asymptomatic for years. However, chronic volume overload eventually leads to progressive LV dilation, increased wall stress, and myocardial oxygen demand. Over time, the compensatory mechanisms fail, leading to impaired myocardial contractility, reduced ejection fraction, and ultimately, left ventricular systolic dysfunction and overt heart failure. The large stroke volume ejected into the aorta and the subsequent diastolic run-off cause a wide pulse pressure and characteristic peripheral signs.

Aortic regurgitation is a relatively common valvular heart disease. Its prevalence varies depending on the etiology and age group. In developed countries, it is often due to congenital bicuspid aortic valves, degenerative valve changes, or aortic root dilation (e.g., hypertension, Marfan syndrome). In developing countries, rheumatic heart disease remains a significant cause.

• Prevalence: Studies estimate a prevalence of mild AR in approximately 5-10% of the general adult population, with moderate-to-severe AR affecting about 0.5-1% of adults.


• Age: Prevalence increases with age, primarily due to degenerative changes in the aortic valve and aortic root.


• Gender: Aortic regurgitation tends to be slightly more common in males, particularly in cases related to bicuspid aortic valves or aortopathy.

• Bicuspid aortic valve
• Uncontrolled hypertension
• Marfan syndrome and other connective tissue disorders
• History of rheumatic fever
• Infective endocarditis
• Syphilis
• Ankylosing spondylitis
• Systemic lupus erythematosus (SLE)
• Rheumatoid arthritis
• Aortic aneurysm or dissection
• Aging

A. Early Symptoms

• Often asymptomatic for many years


• Awareness of heart beat (palpitations), especially when lying down


• Mild fatigue B. Common Symptoms


• Dyspnea on exertion


• Orthopnea (shortness of breath when lying flat)


• Paroxysmal nocturnal dyspnea (PND)


• Angina pectoris (chest pain), particularly nocturnal


• Fatigue and weakness


• Dizziness or lightheadedness


• Palpitations, especially forceful or pounding sensation C. Advanced Symptoms


• Severe dyspnea at rest


• Peripheral edema (swelling in legs and ankles)


• Ascites (fluid accumulation in abdomen)


• Syncope (fainting) or near-syncope


• Signs of right-sided heart failure (e.g., jugular venous distention) D. Emergency Symptoms


• Acute onset of severe dyspnea


• Pulmonary edema


• Acute chest pain mimicking myocardial infarction


• Shock (hypotension, altered mental status, cool extremities)

• Vital Signs: Wide pulse pressure (elevated systolic, low diastolic), tachycardia.
• Inspection: Visible carotid pulsations (Corrigan's sign), head bobbing with each heartbeat (de Musset's sign).
• Palpation: Hyperdynamic and displaced apical impulse (down and to the left), forceful "water-hammer" pulse (Corrigan's pulse) in radial or femoral arteries.

• Peripheral: Pistol-shot sounds over femoral artery (Traube's sign), Duroziez's sign (systolic murmur over femoral artery when compressed proximally, diastolic murmur when compressed distally).

A. Clinical Assessment
Detailed history focusing on symptoms, risk factors, and comorbid conditions. Comprehensive physical examination. B. Laboratory Testing
Routine blood tests, inflammatory markers, cardiac biomarkers if acute symptoms. C. Imaging Studies
Echocardiography (Transthoracic and Transesophageal), Cardiac MRI, CT Angiography, Chest X-ray. D. Functional Tests
Exercise stress testing (for asymptomatic patients to assess exercise tolerance and symptom induction). E. Biopsy Findings
Not routinely used for AR diagnosis itself, but may be indicated for underlying systemic conditions (e.g., vasculitis, endomyocardial biopsy for specific cardiomyopathies). F. Genetic Testing
Considered for patients with suspected connective tissue disorders (e.g., Marfan, Ehlers-Danlos) or familial aortopathy. G. Differential Diagnosis
Other causes of heart failure, other cardiac murmurs (e.g., VSD, PDA, mitral regurgitation), anemia.

Complete Blood Count (CBC)
Type: Blood Test
Purpose: To check for anemia (which can exacerbate symptoms) or signs of infection (e.g., endocarditis).
Expected Findings: Normal, or anemia in severe chronic disease, leukocytosis in infection.
Interpretation: Anemia may worsen symptoms; leukocytosis points to infection. Erythrocyte Sedimentation Rate (ESR) and C-reactive Protein (CRP)
Type: Blood Test
Purpose: To screen for systemic inflammation, often elevated in rheumatic fever, endocarditis, or autoimmune conditions.
Expected Findings: Normal, or elevated in inflammatory conditions.
Interpretation: Elevated levels suggest an inflammatory etiology. Brain Natriuretic Peptide (BNP) or N-terminal pro-BNP (NT-proBNP)
Type: Blood Test
Purpose: Biomarker for cardiac stress and heart failure severity.
Expected Findings: Elevated in heart failure or significant LV dysfunction.
Interpretation: Higher levels correlate with worse LV function and heart failure prognosis. Cardiac Troponins
Type: Blood Test
Purpose: To rule out acute myocardial injury or infarction, especially in patients presenting with chest pain.
Expected Findings: Normal, or elevated in myocardial injury.
Interpretation: Elevated levels indicate myocardial damage. Renal Function Tests (Creatinine, BUN) and Electrolytes
Type: Blood Test
Purpose: To assess kidney function, which can be affected by heart failure and guide diuretic therapy.
Expected Findings: Normal, or impaired in advanced heart failure or diuretic use.
Interpretation: Important for monitoring treatment and assessing overall systemic impact. Blood Cultures
Type: Blood Test
Purpose: To identify causative organisms in suspected infective endocarditis.
Expected Findings: Negative, or positive for bacteria/fungi in endocarditis.
Interpretation: Essential for guiding antibiotic therapy in infective endocarditis. Syphilis Serology (VDRL/RPR, FTA-ABS)
Type: Blood Test
Purpose: To diagnose tertiary syphilis as a cause of aortitis and AR.
Expected Findings: Negative, or positive in syphilis.
Interpretation: Positive tests indicate past or active syphilis infection.

Echocardiography (Transthoracic Echocardiogram - TTE)
Purpose: The primary diagnostic tool. It directly visualizes the aortic valve morphology, assesses severity of regurgitation, measures LV dimensions and function, and estimates pulmonary artery pressure.
Typical Findings: Diastolic flow reversal in the aortic root/LV outflow tract (color Doppler), LV dilation and hypertrophy, incomplete valve coaptation, fluttering of the anterior mitral leaflet (Austin Flint), and evaluation of aortic root dimensions.
Clinical Importance: Confirms diagnosis, quantifies severity, assesses LV remodeling, guides management decisions (medical vs. surgical timing). Transesophageal Echocardiogram (TEE)
Purpose: Provides higher resolution images of the aortic valve and root, especially useful when TTE is suboptimal, for pre-surgical planning, or in suspected endocarditis/aortic dissection.
Typical Findings: Detailed visualization of leaflet pathology (vegetations, perforations), precise assessment of regurgitant jet origin and severity, and comprehensive evaluation of the aortic root.
Clinical Importance: Essential for difficult cases, pre-operative planning, and diagnosing complications like endocarditis. Cardiac Magnetic Resonance Imaging (CMR)
Purpose: Gold standard for accurate quantification of ventricular volumes, mass, and ejection fraction, and can precisely measure regurgitant fraction without geometric assumptions. Excellent for assessing aortic root dimensions and aortic dissection.
Typical Findings: LV dilation, hypertrophy, quantification of regurgitant volume and fraction, assessment of aortic root and ascending aorta. Late gadolinium enhancement can identify myocardial fibrosis.
Clinical Importance: Highly accurate for severity assessment and LV function, particularly useful when echocardiographic windows are poor or for complex aortic root pathology. Computed Tomography (CT) Angiography
Purpose: Primarily used for detailed visualization of the aortic root and ascending aorta, particularly for evaluating aneurysms, dissections, and guiding surgical planning.
Typical Findings: Precise measurements of aortic dimensions, detection of aortic dissection or aneurysm.
Clinical Importance: Crucial for evaluating the extent of aortopathy and planning surgical approaches involving the aorta. Chest X-ray
Purpose: Provides a general assessment of cardiac size and pulmonary vasculature.
Typical Findings: Cardiomegaly (enlarged heart silhouette), signs of pulmonary congestion in advanced heart failure.
Clinical Importance: Initial screening tool for cardiomegaly and heart failure, but not specific for AR.

• Mitral Regurgitation: Both cause LV volume overload and symptoms of heart failure, but MR has a systolic murmur at the apex radiating to the axilla.
• Ventricular Septal Defect (VSD): Can cause a systolic murmur, but typically holosystolic and accompanied by a thrill; a small VSD can be confused with an Austin Flint murmur.
• Patent Ductus Arteriosus (PDA): Produces a continuous "machinery" murmur, distinct from the early diastolic decrescendo of AR.
• Anemia/Hyperthyroidism: Can cause a hyperdynamic circulation with a wide pulse pressure and functional murmurs, but absence of specific AR valvular pathology.
• Physiological Murmur/Flow Murmur: Benign murmurs that can occur in hyperdynamic states, distinguished by absence of pathological findings on echocardiography.
• Other causes of heart failure: Distinguish from primary myocardial dysfunction or other valvular diseases through imaging.

• Heart Failure: Due to chronic LV volume overload leading to systolic dysfunction.
• Sudden Cardiac Death: Although rare, it can occur in patients with severe AR, even if asymptomatic, possibly due to arrhythmias or myocardial ischemia.
• Infective Endocarditis: Risk of bacterial infection of the damaged valve.
• Arrhythmias: Atrial fibrillation and ventricular arrhythmias can occur due to cardiac remodeling.
• Myocardial Ischemia/Angina: Increased myocardial oxygen demand and reduced diastolic coronary perfusion time.
• Aortic Dissection/Rupture: In cases of underlying aortopathy (e.g., Marfan syndrome).

A. Lifestyle Modifications

• Sodium Restriction: To manage fluid retention and hypertension.


• Regular Exercise: For asymptomatic patients with normal LV function, moderate activity is generally encouraged, but competitive sports may be restricted in severe AR.


• Blood Pressure Control: Strict management of hypertension to reduce aortic stress.


• Smoking Cessation: To improve overall cardiovascular health. B. Preventive Measures


• Antibiotic Prophylaxis for Endocarditis: No longer routinely recommended for most AR patients, but considered for those with prosthetic valves or a history of endocarditis.


• Rheumatic Fever Prevention: Prompt treatment of streptococcal infections to prevent recurrent rheumatic fever.


• Genetic Counseling: For patients with hereditary aortopathies (e.g., Marfan syndrome). C. Medical Treatment

• Immediate Vasodilators: IV nitroglycerin or nitroprusside to reduce afterload.


• Inotropes: If hypotensive (e.g., dobutamine) with careful monitoring.


• Diuretics: IV furosemide for pulmonary edema.


• Emergency Surgery: Urgent AVR is indicated for acute severe AR with hemodynamic instability.


• Intra-aortic Balloon Pump (IABP): Contraindicated in AR as it exacerbates regurgitation.

The prognosis for aortic regurgitation depends on its severity, the presence of symptoms, the degree of left ventricular dysfunction, and the timing of intervention. Asymptomatic patients with mild-to-moderate AR and normal LV function generally have a good prognosis and may remain stable for many years. However, chronic severe AR, especially once symptoms develop or LV systolic dysfunction ensues, carries a significantly worse prognosis without surgical intervention. With successful AVR, the prognosis improves dramatically, with normalization of LV function in many cases. Long-term outcomes after surgery are generally excellent, but depend on baseline LV function and the presence of comorbidities.

Primary Prevention: Management of Hypertension: Strict blood pressure control to prevent aortic root dilation.

• Prompt Treatment of Streptococcal Infections: To prevent rheumatic fever.


• Screening for Genetic Syndromes: Early diagnosis and prophylactic aortic surgery for individuals with Marfan syndrome or other aortopathies.

• Adherence to Medical Therapy: For symptom control and prevention of complications.

The following homeopathic remedies have been historically indicated for symptoms associated with Aortic Regurgitation. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Aortic Regurgitation.